Osiris Therapeutics, Inc. (NASDAQ:OSIR)

CAPS Rating: 1 out of 5

A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.

Recs

0
Player Avatar pchop123 (79.56) Submitted: 2/15/2013 12:39:03 AM : Underperform Start Price: $7.40 OSIR Score: +5.45

gravity taking over

Featured Broker Partners


Advertisement